Highlights from the 2021 agenda

We’re currently building the agenda. If you’d like to be involved as a speaker or sponsor, please contact Saskia Burbach at Saskia.Burbach@thomsonreuters.com.

9:00am – 10:00am (ET)

Embrace the stakeholder: why collaboration is the key for clinical innovation

  • Discover how pre-competitive, interdisciplinary, and interdepartmental collaboration is re-shaping the way we develop and operationalise clinical trials
  • From 5-year to 6-month planning - how to implement and scale innovations under increased visibility and timeline pressure through change management
  • Reshape the trial design process around patient need through increased flexibility and opportunity for patient led decision making

Lionel Bascles Global Head, Clinical Sciences & Operation Sanofi

Rachel Edwards Exec Director Global Development Operations Amgen

Mo Ali VP Digital Analytics and Performance GSK

Kendal Whitlock Metasite Strategic Engagement Lead Boehringer Ingelheim

Moderator:: Marie Lamont President and Chief Operating Officer Inteliquet

11:10am – 12:00pm (ET)

In partnership with:
PRA Life Sciences

Trial decentralisation in practice

  • A practical guide to how data consensus, intelligent process design, and talent optimisation can be used DCTs to drive operational efficiency, reduce trial costs and ensure successful and coherent external vendor strategies
  • Discover how integration with pre-existing health networks can streamline trial operations and increase flexibility
  • Identify the practical barriers to operational decentralisation and how technological solutions to e-consent, telemedicine, ECON and devices can be employed to mitigate these challenges

Craig Lipset Advisor and Founder Clinical Innovation Partners

Munther Baara VP Product Strategy and innovation EDETEK

Grace Cordovano, PhD, BCPA Board-Certified Patient Advocate & Founder Enlightening Results

Sam Hariry Global Head, Clinical Innovation Novartis

Moderator: Kent Thoelke EVP & Chief Scientific Officer PRA Health Sciences

10:30am – 10:45am (ET)

Advanced Analytical Approaches to Enrollment Forecasting and Screening Impacts during the Pandemic

  • Discover a modern stacked approach to enrollment forecasting that leverages historical data as well as within-time-series predictive modeling
  • Understand the Impacts of the pandemic on enrollment and screening across Therapy Area and region
  • Discuss future applications for these capabilities across other clinical operations use cases"

Rohit Nambisan President Lokavant

12:00pm – 12:15pm (ET)

Grow your post COVID DCT capabilities

  • How to build and define remote data capture processes with local sites to ensure consistency in reporting
  • Align your stakeholders to scale study assessment capabilities and drive greater opportunities for decentralization.

Rachel Soon Innovation Project Manager Novartis

11:10am – 12:00pm (ET)

In partnership with:
Halloran Consulting

Panel: Employ cross-platform data standardisation to drive novel endpoints

  • Understand the key pre-trial measures needed to enable interoperability between digital tools, sites and data capture measures
  • Utilise big data, AI and ML to prioritise data outputs, identify novel endpoints and build endpoint flexibility into trial design
  • Discover the tools and projects currently driving the future of agile, data driven trial design

John Zibert CEO Studies and me

Ralph A. DeMasi, Ph.D. VP, Head of Biostatistics and Data Management ViiV Healthcare

Haider Alleg Global Head Of Digital Excellence Ferring

Mimi Huizinga VP and Head, US Oncology Medical Novartis

Chair: Todd Johnson, MPH, MBA Principal Consultant, Organizational Solutions Halloran Consulting